Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice.
Tomas BuchlerIgor KissJana HornovaOndrej FialaMarketa WiesnerovaMichal SvobodaJiri SilarKaterina KopeckovaAlexandr PoprachJindrich FinekLubos PetruzelkaBohuslav MelicharPublished in: Targeted oncology (2020)
Patients treated with aflibercept in real-world clinical practice achieved similar survival outcomes as those treated within randomised trials. Cumulative survival data provide a benchmark for future studies and enable indirect comparisons with other treatment sequences used in mCRC.